Isosulfan Blue Injection 1% is the only commercially available FDA-approved blue dye indicated for sentinel lymph node mapping.
Isosulfan Blue Injection 1% is
- FDA-approved as bioequivalent to Lymphazurin 1%†
- Isosulfan Blue injection 1% has been used in sentinel lymph node mapping for more then 30 years†
- Isosulfan Blue has exceptionally high purity of at least 99%¥
lsosulfan Blue Injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities.π
Isosulfan Blue is an important part of Mylan’s growing oncology portfolio
- Mylan now offers more than 40 therapies, from treatments for solid tumors and cancers of the blood to supportive care‡